255 related articles for article (PubMed ID: 11529279)
1. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
Chanez P
Eur Respir J; 2001 Aug; 18(2):249-50. PubMed ID: 11529279
[No Abstract] [Full Text] [Related]
2. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
3. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
Solèr M; Matz J; Townley R; Buhl R; O'Brien J; Fox H; Thirlwell J; Gupta N; Della Cioppa G
Eur Respir J; 2001 Aug; 18(2):254-61. PubMed ID: 11529281
[TBL] [Abstract][Full Text] [Related]
4. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab.
Easthope S; Jarvis B
Drugs; 2001; 61(2):253-60; discussion 261. PubMed ID: 11270941
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
Casale TB;
Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
[TBL] [Abstract][Full Text] [Related]
7. Anti-IgE monoclonal antibody for the treatment of the asthma and other manifestations related to allergic diseases.
Sarinho E; Cruz AA
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S127-32. PubMed ID: 17136288
[TBL] [Abstract][Full Text] [Related]
8. [Omralizumab (Xolair) in severe persistent allergic asthma].
Schleich F; Manise M; Louis R
Rev Med Liege; 2009; 64(5-6):313-7. PubMed ID: 19642466
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in asthma: is the therapeutic window too small?
Bhat KD; Calhoun WJ
Chest; 2011 Jan; 139(1):8-10. PubMed ID: 21208873
[No Abstract] [Full Text] [Related]
10. World Asthma and COPD Forum. Clinical trial results with omalizumab.
D'Amato G
IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
[No Abstract] [Full Text] [Related]
11. [Dermatological implications of omalizumab, an anti-IgE antibody].
Di Lucca-Chrisment J
Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
[TBL] [Abstract][Full Text] [Related]
12. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
14. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab for asthma: indications, off-label uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):183-92. PubMed ID: 20807194
[TBL] [Abstract][Full Text] [Related]
17. Does anti-IgE therapy help in asthma? Efficacy and controversies.
Avila PC
Annu Rev Med; 2007; 58():185-203. PubMed ID: 17059361
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of the expression of FcεRI and IgE on basophils and dendritic cells in association with basophil function in two patients with severe allergic asthma treated with Omalizumab.
Pereira Santos MC; Campos Melo A; Caetano A; Caiado J; Mendes A; Pereira Barbosa M; Branco Ferreira M
Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):38-40. PubMed ID: 25781192
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in asthma: an update on recent developments.
Humbert M; Busse W; Hanania NA; Lowe PJ; Canvin J; Erpenbeck VJ; Holgate S
J Allergy Clin Immunol Pract; 2014; 2(5):525-36.e1. PubMed ID: 25213045
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.
Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV
Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
